terized by proteinuria, renal failure, and focal segmental glomerulosclerosis. By using a noninfectious HIV-1 DNA construct lacking the gag and pol genes, three transgenic mouse lines have been generated that develop a syndrome remarkably similar to the human disease. In the present study, we have characterized in detail one of these lines, Tg26. In Tg26 mice, proteinuria was detectable at -24 days of age, followed by severe nephrotic syndrome and rapid progression to end-stage renal failure. Renal histology showed focal segmental glomerulosclerosis and microcystic tubular dilatation. Indirect immunofluorescence studies demonstrated increased accumulation of the basement membrane components laminin, collagen type IV, and heparan sulfate proteoglycan. The viral protein Rev was present in sclerotic glomeruli. Northern blot analysis of total renal RNA showed expression of viral genes prior to the appearance of histologic renal disease, with greatly diminished viral gene expression late in the disease course. Kidneys from transgenic mice expressed increased steady-state levels of collagen al(IV) mRNA when glomerulosclerosis was present. We conclude that the presence of HIV-1 genes is associated with progressive renal dysfunction and glomerulosclerosis in transgenic mice.
Among the protean manifestations now recognized as sequelae of infection with human immunodeficiency virus type 1 (HIV-1) is a renal syndrome, termed HIV-associated nephropathy. This syndrome is characterized clinically by heavy proteinuria, often with the nephrotic syndrome, and a high incidence of progression to end-stage renal disease (1) (2) (3) (4) (5) (6) . Pathologically, the most common glomerular lesions in HIV-associated nephropathy are focal segmental glomerulosclerosis and microcystic tubular dilatation (6) . Some of the remaining patients have mesangial proliferation (7) .
Recently, we developed transgenic mouse lines that bear HIV-1 genes. A defective form of the HIV-1 provirus that lacks 3 kilobases (kb) of sequence overlapping the gag and pol sequences was introduced into mice as a transgene. Transgenic lines derived from three founder animals developed proteinuria, progressive renal failure, glomerulosclerosis, and microcystic tubular dilatation. In the present study, we describe in detail the clinical, pathological, and molecular biological manifestations of the renal disease in one of these transgenic mouse lines (Tg26).
MATERIALS AND METHODS
Transgenic Mice. The transgene, 7.4 kb long, consisted of the proviral HIV genome, lacking 3 kb of sequence overlapping the gag and pol genes. The remaining proviral sequence included the 5' and 3' long terminal repeats (LTRs) and the env, tat, nef, rev, vif, vpr, and vpu genes (8) . The transgene was introduced into male pronuclei of FVB/N mouse oocytes, resulting in nine founder animals, all of which remained healthy. Male founder mice were back-crossed with normal female FVB/N mice to produce the F1 generation. Three of the eight male founder animals (Tg22, Tg25, and Tg26) gave rise to lines that developed progressive renal disease in the F1 generation, and all three of these founders had unique restriction fragment length polymorphisms for the transgene (9) .
Southern Blot Analysis. Ten micrograms of tail DNA was digested with EcoRI, electrophoresed through 0.7% agarose gels, and transferred to nylon membranes. DNA was probed with a cDNA encoding the HIV-1 nefgene (10) radioactively labeled using [32P] Affinity-purified fluoresceinated goat anti-rabbit antibody (Kirkegaard and Perry), diluted 1:40 in PBS, was applied for 60 min. The specific rabbit antisera used included anti-mouse laminin and anti-mouse collagen type IV (kindly provided by Hynda Kleinman, National Institute of Dental Research), anti-mouse basement membrane heparan sulfate proteoglycan core protein (11) , and antiserum directed against residues 26-51 of Rev.
Extraction ofTotal RNA and Northern Blot Analysis. Mouse kidneys were snap frozen in liquid nitrogen and total renal RNA was isolated by centrifugation through cesium chloride (12) . RNA (10,Mg) was electrophoresed through 1% agarose/ formaldehyde gels, transferred to nylon filters, and fixed by baking for 2 hr at 80'C. The following cDNA probes were 32P-labeled using the random-primer method: a 1.2-kb Hind-III fragment of nef cDNA (10), a 1.5-kb EcoRI-HindIII fragment from mouse laminin B2 chain cDNA (13), a 0.8-kb Pst I-Ava I fragment of mouse collagen al(IV) cDNA (14), and a human ribosomal S14 protein cDNA (American Type Culture Collection 59246). Hybridization was carried out at 37°C in 50% formamide/dextran sulfate (0.1 g/ml)/5x SSC/10 mM Tris-HCI, pH 7.5/4x Denhardt's solution/ denatured salmon sperm DNA (0.1 mg/ml). The filters were washed at 55°C in 0.1x SSC/0.1% SDS. Autoradiographic exposures were made at -70°C, and the blots were scanned on a Phosphoimager (Molecular Dynamics, Sunnyvale, CA), which provided a direct measure of radioactivity.
Statistics. Data are expressed as mean ± standard deviation. Student of the nephrotic syndrome. In seven normal mice, serum albumin was 3.5 ±f 0.5 g/dl and serum cholesterol was 143 ± 26 mg/dl, whereas in seven age-matched transgenic mice with edema, serum albumin was 2.4 ± 0.5 g/dl (P < 0.01) and serum cholesterol was 387 ± 148 mg/dl (P < 0.001). Death from uremia occurred within 10-15 days of the onset of edema.
To evaluate the course of the renal disease, we measured indices of renal function in a litter of mice longitudinally from birth. Urinary protein excretion, as measured by the ratio of urine protein concentration to urine creatinine concentration, was comparable in heterozygous transgenic mice and normal littermates at 19 days of age ( Fig. 2A) . At '-24 days of age, the transgenic mice developed proteinuria, which progressively increased with time. By 40 days of age, blood urea nitrogen was also significantly elevated in the heterozygous transgenic mice as compared to normal littermates (Fig. 2B) Kidneys harvested from transgenic animals at 45 days of age showed a spectrum of pathologic changes (Fig. 3) . The renal tubules were notable for microcystic tubular dilatation (Fig. 3B ) and atrophy and simplification of the tubular epithelium (Fig. 3D ). Tubules were filled by densely staining PA-posictuive mate-rial (Fig. 3A B, E and F) . The-re was a sparse monocytic interstitial infiltrate and minimal interstitial fibrosis (Fig. 3D) . Essentially all glomeruli manifested increased PAS-positive material, some with segmental (Fig. 3 Proc. NaM Acad Sci. USA 89 (1992) E and F) and others with global sclerosis (Fig. 3G) . A minority of glomeruli showed mesangial hypercellularity (data not shown). Glomerular parietal and visceral epithelial cells appeared reactive, with enlargement and vacuolization ( Fig. 3 E and F) . Glomerular synechiae were present but epithelial crescents were absent. Silver staining confirmed that the PAS-positive material within the glomerulus was composed of matrix components and demonstrated duplication of Bowman's capsule (Fig. 3H) (Fig. 4 B, D, and F) . By contrast, Bowman's capsule, the tubular basement membranes, and interstitial regions of the kidneys of transgenic mice and normal littermates did not show differences in staining. Immunofluorescent studies demonstrated Rev protein in sclerotic glomeruli (Fig. 4H) ; similar studies with specific antisera directed against gp4l, gpl20, Tat, and Nef were negative (data not shown).
Northern blot analysis of total renal RNA was performed with a nef cDNA probe that overlaps the proviral 3' LTR and is, therefore, expected to hybridize with all proviral mRNAs (Fig. 5) . Proviral mRNA of two size classes, 2 kb and 4 kb, was present at the earliest time points examined, 18 days (prior to the onset of proteinuria) and 28 days (after the onset of proteinuria but prior to the appearance of histologic changes in the kidney). By the time morphologic changes were well-established in the kidney, the expression of viral genes was severely attenuated (54 and 220 days).
In the normal mouse kidney, levels of laminin B2 chain and collagen al(IV) mRNA were highest at the earliest time point examined, 18 days, and declined with age, as has been reported (15) . In the kidneys from transgenic mice, laminin B2 mRNA followed a quantitatively similar pattern. Transgenic kidneys expressed steady-state levels of collagen al(IV) transcripts comparable to normal mouse kidneys at 18 and 28 days. In contrast, the steady-state levels of collagen al(IV) mRNA were increased compared to normal littermates at day 54 and day 220. The ratio of collagen al(IV) mRNA to S14 ribosomal protein mRNA was calculated to provide a normalized measure of steady-state collagen type IV mRNA expression. In normal mice, this ratio was 14.2 at 18 days, 2.4 at 28 days, 0.1 at 54 days, and 0 at 220 days, indicating no detectable collagen al(IV) transcripts at the final time point. In the transgenic mouse, this ratio was 16.2 at 18 days, 2.9 at 28 days, 2.4 at 54 days, and 13.8 at 220 days, indicating increased steady-state amounts of collagen al(IV) mRNA in older transgenic mice compared to normal mice.
DISCUSSION
HIV-associated nephropathy is increasingly recognized as a complication of HIV-1 infection particularly in children (3, 5) and drug abusers (6) . Despite the importance of this problem, the fundamental disease mechanisms remain to be elucidated. HIV-associated nephropathy may result from the presence ofreplicating virus within ren:l cells or from a direct or indirect effect of viral gene products acting upon target renal cells. It has been suggested that human glomerular cells express CD4 (16) and thus could be potential targets for HIV-1 infection. Alternatively, CD4-negative mesenchymal renal cells might be susceptible to infection, as has been demonstrated in vitro for other mesenchymal cell types that do not express detectable amounts of CD4 (17) . It has been suggested that HIV-1 gene products may also cause disease in certain tissues directly. For example, Tat can be released by infected lymphocytes and can be taken up by uninfected target cells (18) . Furthermore, the introduction of Tat into culture medium stimulates the growth of spindle cells isolated from Kaposi lesions from patients with AIDS (19) and mice transgenic for the tat gene under the control of the HIV-1 LTR develop mesenchymal tumors (20) .
Although p24 core protein of HIV and genomic DNA sequences have been identified in both glomeruli and tubules from patients with HIV-associated nephropathy (21) , it remains unclear whether replicating virus is present in the kidney and whether it is virus or viral protein products that are responsible for mesangial sclerosis. In the present study, the insertion of a construct with viral LTRs and encoding env, tat, rev, pef, vif, vpr, and vpu genes was associated with the appearance of progressive glomerular and tubular abnormalities in heterozygous mice that closely resemble HIVassociated nephropathy. Thus, it appears that HIV-1 gene products alone are capable of inducing many of the features of HIV-associated nephropathy.
The pathogenic mechanisms by which viral genes might produce glomerulosclerosis and tubular abnormalities in this model are unknown. Glomerular immune deposits appeared late in the disease course and did not appear to be specific. Thus, the glomerulosclerosis does not appear to be the result of immune-complex disease. Alternatively, viral gene products may be expressed in kidney or may be produced in peripheral tissues and accumulate in kidney. Viral gene products may be cytotoxic or may act upon renal parenchymal cells to stimulate extracellular matrix protein synthesis. The demonstration of Rev protein in sclerotic glomeruli would be consistent with either local production or nonspecific trapping of serum-derived material. The absence of other viral proteins in kidney may indicate that these genes are not transcribed or translated or that the proteins are present in quantities too small to be detected.
The expanded mesangial compartment was occupied by increased amounts of laminin, collagen type IV, and heparan sulfate proteoglycan. Collagen al(IV) mRNA was increased coincident with the appearance of glomerulosclerosis. This finding is consistent with either increased gene transcription or prolonged mRNA half-life, and these cannot be distinguished by the Northern blot analysis presented here. By contrast, laminin B2 mRNA was not substantially increased at any time point examined. Thus, it appears that the mechanisms that result in increased accumulation of basement membrane components in this model are complex and operate at both transcriptional and posttranscriptional levels.
Renal pathology in transgenic mice may be a consequence of mechanisms independent of the expression of the transgene itself, such as insertional inactivation leading to nephrotic syndrome and progressive glomerulosclerosis (22 
